Modified factor IX polypeptides and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8778870
APP PUB NO 20120308540A1
SERIAL NO

13373118

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Modified Factor IX (FIX) polypeptides and uses thereof are provided. Such modified FIX polypeptides include FIXa and other forms of FIX. Among the modified FIX polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GC BIOPHARMA CORP107 IHYEON-RO 30BEON-GIL GIHEUNG-GU YONGIN-SI GYEONGGI-DO 16924

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blouse, Grant Ellsworth Copenhagen S, DK 4 56
Madison, Edwin L San Francisco, US 54 991
Thanos, Christopher San Francisco, US 46 493

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 15, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00